Zobrazeno 1 - 10
of 10 020
pro vyhledávání: '"Neyts, J"'
Publikováno v:
In Biologicals September 2021 73:1-7
Autor:
Lin Y; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Khan M; Max Planck Research Unit for Neurogenetics, Frankfurt, Germany., Weynand B; KU Leuven Department of Imaging and Pathology, Division of Translational Cell and Tissue Research, Leuven, Belgium., Laporte M; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Coenjaerts F; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Babusis D; Gilead Sciences Incorporated, Foster City, CA, USA., Bilello JP; Gilead Sciences Incorporated, Foster City, CA, USA., Mombaerts P; Max Planck Research Unit for Neurogenetics, Frankfurt, Germany., Jochmans D; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium. johan.neyts@kuleuven.be.; VirusBank Platform, KU Leuven, Leuven, Belgium. johan.neyts@kuleuven.be.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 05; Vol. 15 (1), pp. 7765. Date of Electronic Publication: 2024 Sep 05.
Autor:
Do TND; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium., Abdelnabi R; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium; The VirusBank Platform, Gaston Geenslaan, B-3000, Leuven, Belgium., Boda B; Epithelix Sàrl, 18 Chemin des Aulx, Plan-les-Ouates, CH-1228, Geneva, Switzerland., Constant S; Epithelix Sàrl, 18 Chemin des Aulx, Plan-les-Ouates, CH-1228, Geneva, Switzerland., Neyts J; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium; The VirusBank Platform, Gaston Geenslaan, B-3000, Leuven, Belgium. Electronic address: Johan.Neyts@kuleuven.be., Jochmans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium. Electronic address: Dirk.Jochmans@kuleuven.be.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Sep 03; Vol. 231, pp. 105994. Date of Electronic Publication: 2024 Sep 03.
Autor:
Gouttenoire J; Division of Gastroenterology and Hepatology, Lausanne University Hospital and, University of Lausanne, Lausanne, Switzerland. Electronic address: jerome.gouttenoire@chuv.ch., Neyts J; Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Katholieke Universiteit (KU) Leuven, Leuven, Belgium. Electronic address: johan.neyts@kuleuven.be.
Publikováno v:
Gastroenterology [Gastroenterology] 2024 Sep; Vol. 167 (4), pp. 652-653. Date of Electronic Publication: 2024 May 23.
Autor:
Lachhab S; Laboratory of Biomolecular and Medicinal Chemistry, Faculty of Science Semlalia, University Cadi Ayyad, Marrakech, Morocco., El Mansouri AE; Department of Chemistry, University of the Free State, P.O. Box 339, Bloemfontein, 9300, South Africa., Mehdi A; ICGM, Université Montpellier, CNRS, ENSCM, Montpellier, France., Dennemont I; Antiparasite Chemotherapy, CNRS, BioCIS, Université Paris-Saclay, Chatenay-Malabry, 92290, Paris, France., Neyts J; Rega Institute for Medical Research, KULeuven, Louvain, Belgium., Jochmans D; Rega Institute for Medical Research, KULeuven, Louvain, Belgium., Andrei G; Rega Institute for Medical Research, KULeuven, Louvain, Belgium., Snoeck R; Rega Institute for Medical Research, KULeuven, Louvain, Belgium., Sanghvi YS; Rasayan Inc., 2802 Crystal Ridge Road, Encinitas, CA, 92024-6615, USA., Ait Ali M; Laboratory of Biomolecular and Medicinal Chemistry, Faculty of Science Semlalia, University Cadi Ayyad, Marrakech, Morocco., Loiseau PM; Antiparasite Chemotherapy, CNRS, BioCIS, Université Paris-Saclay, Chatenay-Malabry, 92290, Paris, France., Lazrek HB; Laboratory of Biomolecular and Medicinal Chemistry, Faculty of Science Semlalia, University Cadi Ayyad, Marrakech, Morocco. hblazrek50@gmail.com.
Publikováno v:
Molecular diversity [Mol Divers] 2023 Oct; Vol. 27 (5), pp. 2147-2159. Date of Electronic Publication: 2022 Oct 17.
Autor:
Kiemel D; Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg, Germany., Kroell AH; Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg, Germany., Denolly S; Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg, Germany., Haselmann U; Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg, Germany., Bonfanti JF; Janssen Infectious Diseases Discovery, Janssen-Cilag, Val de Reuil, France.; Evotec, Toulouse, France., Andres JI; Discovery Chemistry, Janssen R&D, a Johnson & Johnson company, Toledo, Spain., Ghosh B; Discovery Chemistry, Janssen R&D, a Johnson & Johnson company, Spring House, PA, USA., Geluykens P; Discovery, Charles River Beerse, Beerse, Belgium., Kaptein SJF; Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium., Wilken L; Leibniz Institute of Virology, Hamburg, Germany., Scaturro P; Leibniz Institute of Virology, Hamburg, Germany., Neyts J; Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium., Van Loock M; Janssen Global Public Health, Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Goethals O; Janssen Global Public Health, Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Bartenschlager R; Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Heidelberg, Germany. ralf.bartenschlager@med.uni-heidelberg.de.; German Centre for Infection Research, Heidelberg partner site, Heidelberg, Germany. ralf.bartenschlager@med.uni-heidelberg.de.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 19; Vol. 15 (1), pp. 6080. Date of Electronic Publication: 2024 Jul 19.
Autor:
Gouttenoire J; Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Neyts J; KU Leuven Department of Microbiology, Immunology, and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2023 Dec 01; Vol. 78 (6), pp. 1695-1697. Date of Electronic Publication: 2023 Jun 12.
Autor:
Perraud V; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Vanderhoydonck B; Center for Innovation and Stimulation of Drug Discovery (Cistim) Leuven, Belgium., Bouvier G; Institut Pasteur, Université Paris Cité, CNRS UMR3528, Structural Bioinformatics Unit, F-75015, Paris, France., Dias de Melo G; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Kilonda A; Center for Innovation and Stimulation of Drug Discovery (Cistim) Leuven, Belgium., Koukni M; Center for Innovation and Stimulation of Drug Discovery (Cistim) Leuven, Belgium., Jochmans D; Katholieke Universiteit Leuven, Leuven, Belgium., Rogée S; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Ben Khalifa Y; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Kergoat L; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Lannoy J; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France., Van Buyten T; Katholieke Universiteit Leuven, Leuven, Belgium., Izadi-Pruneyre N; Institut Pasteur, Université Paris Cité, CNRS UMR3528, Bacterial Transmembrane Systems Unit, F-75015, Paris, France., Chaltin P; Center for Innovation and Stimulation of Drug Discovery (Cistim) Leuven, Belgium; Centre for Drug Design and Discovery (CD3), Katholieke Universiteit Leuven, Leuven, Belgium., Neyts J; Katholieke Universiteit Leuven, Leuven, Belgium., Marchand A; Center for Innovation and Stimulation of Drug Discovery (Cistim) Leuven, Belgium., Larrous F; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France. Electronic address: florence.larrous@pasteur.fr., Bourhy H; Institut Pasteur, Université Paris Cité, Unité Lyssavirus, Epidémiologie et Neuropathologie, WHO Collaborating Centre for Reference and Research on Rabies, F-75015, Paris, France. Electronic address: herve.bourhy@pasteur.fr.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Apr; Vol. 224, pp. 105838. Date of Electronic Publication: 2024 Feb 18.
Autor:
Gadali KE; Laboratoire de Recherche en Développement Durable et Santé, Faculty of Sciences and Technology Gueliz (FSTG), BP549, Marrakech 40000, Morocco; Laboratory of Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Marrakech 40000, Morocco., Rafya M; Laboratoire de Recherche en Développement Durable et Santé, Faculty of Sciences and Technology Gueliz (FSTG), BP549, Marrakech 40000, Morocco., El Mansouri AE; University of the Free State Faculty of Natural and Agricultural Sciences Chemistry Department 205 Nelson Mandela, Bloemfontein, 9301, South Africa., Maatallah M; Laboratory of Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Marrakech 40000, Morocco., Vanderlee A; Institut Européen des Membranes, IEM, UMR 5635, Univ. Montpellier, CNRS, ENSCM, 34095 Montpellier, France., Mehdi A; ICGM, UMR5253 1919, Route de Mende 34293 Montpellier cedex 5, France., Neyts J; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Box 1043, B-3000 Leuven, Belgium., Jochmans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Box 1043, B-3000 Leuven, Belgium., De Jonghe S; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Box 1043, B-3000 Leuven, Belgium., Benkhalti F; Laboratoire de Recherche en Développement Durable et Santé, Faculty of Sciences and Technology Gueliz (FSTG), BP549, Marrakech 40000, Morocco., Sanghvi YS; Rasayan Inc, 2802 Crystal Ridge Road, Encinitas, CA 92024-6615, USA., Taourirte M; Laboratoire de Recherche en Développement Durable et Santé, Faculty of Sciences and Technology Gueliz (FSTG), BP549, Marrakech 40000, Morocco. Electronic address: taourirte@uca.ac.ma., Lazrek HB; Laboratory of Molecular Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Marrakech 40000, Morocco. Electronic address: hblazrek50@gmail.com.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2024 Mar 15; Vol. 268, pp. 116235. Date of Electronic Publication: 2024 Feb 16.
Autor:
Kesteleyn B; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Bonfanti JF; Janssen Infectious Diseases Discovery, Janssen-Cilag, Chaussée du Vexin, Val de Reuil 27106, France., Bardiot D; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium., De Boeck B; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Goethals O; Janssen Global Public Health R&D, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Kaptein SJF; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven 3000, Belgium., Stoops B; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Coesemans E; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Fortin J; Janssen Infectious Diseases Discovery, Janssen-Cilag, Chaussée du Vexin, Val de Reuil 27106, France., Muller P; Janssen Infectious Diseases Discovery, Janssen-Cilag, Chaussée du Vexin, Val de Reuil 27106, France., Doublet F; Janssen Infectious Diseases Discovery, Janssen-Cilag, Chaussée du Vexin, Val de Reuil 27106, France., Carlens G; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium., Koukni M; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium., Smets W; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium., Raboisson P; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Chaltin P; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium.; Centre for Drug Design and Discovery (CD3), KU Leuven, Bioincubator 2, Gaston Geenslaan 2, Leuven 3000, Belgium., Simmen K; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Loock MV; Janssen Global Public Health R&D, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium., Neyts J; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven 3000, Belgium.; Global Virus Network (GVN), Baltimore, Maryland 21201, United States., Marchand A; CISTIM Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, Leuven 3001, Belgium., Jonckers THM; Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Mar 14; Vol. 67 (5), pp. 4063-4082. Date of Electronic Publication: 2024 Feb 28.